Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Methylprednisolone (500mg)
Therapeutic Category
Anti-Inflammatories, Immunology
Dosage Form
Injection
Packaging Type
Vial + Water
Packaging
500mg
Price
₹1125/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Volipred 500 Injection contains Methylprednisolone, a potent corticosteroid used to treat a wide range of inflammatory and autoimmune conditions. It helps reduce inflammation, pain, and swelling associated with diseases such as arthritis, severe allergies, skin conditions, and autoimmune disorders. By modulating the immune system, it provides relief in conditions like lupus, uveitis, and inflammatory disorders. This medication is administered by healthcare professionals, usually in a clinical setting, to manage acute episodes of inflammation and improve symptoms quickly.
May cause nausea, weight gain, fluid retention, mood swings, and increased blood sugar.
Used for inflammatory conditions, severe allergies, autoimmune diseases, and post-surgical inflammation.
Use under medical supervision, particularly in those with infections, hypertension, or diabetes. Do not stop abruptly without consulting a doctor.
Store at room temperature, away from moisture and heat. Keep out of reach of children.
Composition : Hydrocortisone (100mg) Injection
Composition : Methylprednisolone (40mg)
Composition : Methylprednisolone (125mg)
Composition : Triamcinolone Acetonide (40mg) Injection
Composition : Deflazacort (6mg)
Composition : Methylprednisolone (1000mg) Injection
Composition : Deflazacort (30mg)
Composition : Deflazacort (18mg) Tablet
Composition : Methylprednisolone (8mg)
Composition : Methylprednisolone (4mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Methylprednisolone 500 mg Injection is a high-dose corticosteroid (glucocorticoid) used for the treatment of severe allergic reactions, acute asthma attacks, autoimmune diseases, neurological inflammation, and emergency hospital conditions. It provides rapid anti-inflammatory and immunosuppressive action. It is a strong critical-care injectable product used in ICUs, emergency wards, pulmonology, neurology, and multispecialty hospitals, making it an important hospital segment medicine for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent hospital and emergency demand, especially from ICUs, physicians, neurologists, pulmonologists, and emergency departments. High-dose steroid injectables are part of standard emergency protocols, ensuring stable institutional procurement and regular turnover.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in critical-care injectable, steroid, and hospital segment formulations with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.
Wholesalers and institutional suppliers benefit from high hospital usage, ICU demand, emergency treatment protocols, and continuous short-course therapies, making it a stable and high-value pharmaceutical category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in steroid injectable formulations can contact Cafoli Lifecare to discuss hospital supply requirements, pricing structure, and PCD pharma franchise opportunities in the critical-care and emergency segment.